Estonia - Estonian - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 50mg 168tk; 50mg 56tk; 50mg 28tk; 50mg 14tk

Estonia - Estonian - Ravimiamet

alembic pharmaceuticals europe limited - lakosamiid - õhukese polümeerikattega tablett - 150mg 28tk; 150mg 168tk; 150mg 14tk

Estonia - Estonian - Ravimiamet

aesica pharmaceuticals gmbh - lakosamiid - õhukese polümeerikattega tablett - 100mg 56tk

Estonia - Estonian - Ravimiamet

ucb pharma sa - lakosamiid - õhukese polümeerikattega tablett - 50mg 14tk

Estonia - Estonian - Ravimiamet

ucb pharma sa - lakosamiid - õhukese polümeerikattega tablett - 200mg 56tk

Estonia - Estonian - Ravimiamet

fresenius kabi polska sp. z o.o. - lakosamiid - infusioonilahus - 10mg 1ml 20ml 5tk; 10mg 1ml 20ml 10tk; 10mg 1ml 20ml 1tk

European Union - Estonian - EMA (European Medicines Agency)

extrovis eu ltd. - lakosamiid - epilepsia - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Estonia - Estonian - Ravimiamet

zenthique limited - lakosamiid - infusioonilahus - 10mg 1ml 20ml 1tk